Cognitive Deficits Completed Phase 2 Trials for Memantine (DB01043)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04033419Memantine for Prevention of Cognitive Decline in Patients With Breast CancerPrevention